Hu Rujiu, Lin Hua, Wang Mimi, Zhao Yuezhen, Liu Haojing, Min Yuna, Yang Xiaojun, Gao Yupeng, Yang Mingming
College of Animal Science and Technology, Northwest A&F University, Yangling, 712100, Shaanxi, China.
J Anim Sci Biotechnol. 2021 Feb 17;12(1):25. doi: 10.1186/s40104-020-00532-4.
Lactobacillus reuteri strains are widely used as probiotics to prevent and treat inflammatory bowel disease by modulating the host's immune system. However, the underlying mechanisms by which they communicate with the host have not been clearly understood. Bacterial extracellular vesicles (EVs) have been considered as important mediators of host-pathogen interactions, but their potential role in commensals-host crosstalk has not been widely studied. Here, we investigated the regulatory actions of EVs produced by L. reuteri BBC3, a gut-associated commensal bacterium of Black-Bone chicken, in the development of lipopolysaccharide (LPS)-induced intestinal inflammation in a chicken model using both in vivo and in vitro experiments.
L. reuteri BBC3 produced nano-scale membrane vesicles with the size range of 60-250 nm. Biochemical and proteomic analyses showed that L. reuteri BBC3-derived EVs (LrEVs) carried DNA, RNA and several bioactive proteins previously described as mediators of other probiotics' beneficial effects such as glucosyltransferase, serine protease and elongation factor Tu. In vivo broiler experiments showed that administration of LrEVs exerted similar effects as L. reuteri BBC3 in attenuating LPS-induced inflammation by improving growth performance, reducing mortality and decreasing intestinal injury. LrEVs suppressed the LPS-induced expression of pro-inflammatory genes (TNF-α, IL-1β, IL-6, IL-17 and IL-8), and improved the expression of anti-inflammatory genes (IL-10 and TGF-β) in the jejunum. LrEVs could be internalized by chicken macrophages. In vitro pretreatment with LrEVs reduced the gene expression of TNF-α, IL-1β and IL-6 by suppressing the NF-κB activity, and enhanced the gene expression of IL-10 and TGF-β in LPS-activated chicken macrophages. Additionally, LrEVs could inhibit Th1- and Th17-mediated inflammatory responses and enhance the immunoregulatory cells-mediated immunosuppression in splenic lymphocytes of LPS-challenged chickens through the activation of macrophages. Finally, we revealed that the reduced content of both vesicular proteins and nucleic acids attenuated the suppression of LrEVs on LPS-induced inflammatory responses in ex vivo experiments, suggesting that they are essential for the LrEVs-mediated immunoregulation.
We revealed that LrEVs participated in maintaining intestinal immune homeostasis against LPS-induced inflammatory responses in a chicken model. Our findings provide mechanistic insight into how commensal and probiotic Lactobacillus species modulate the host's immune system in pathogens-induced inflammation.
罗伊氏乳杆菌菌株作为益生菌被广泛用于通过调节宿主免疫系统来预防和治疗炎症性肠病。然而,它们与宿主沟通的潜在机制尚未完全清楚。细菌细胞外囊泡(EVs)被认为是宿主-病原体相互作用的重要介质,但其在共生菌-宿主串扰中的潜在作用尚未得到广泛研究。在此,我们通过体内和体外实验,研究了乌鸡肠道共生菌罗伊氏乳杆菌BBC3产生的细胞外囊泡在脂多糖(LPS)诱导的鸡肠道炎症发展中的调节作用。
罗伊氏乳杆菌BBC3产生了大小范围为60-250nm的纳米级膜囊泡。生化和蛋白质组学分析表明,罗伊氏乳杆菌BBC3来源的细胞外囊泡(LrEVs)携带DNA、RNA和几种先前被描述为其他益生菌有益作用介质的生物活性蛋白,如葡糖基转移酶、丝氨酸蛋白酶和延伸因子Tu。体内肉鸡实验表明,给予LrEVs在减轻LPS诱导的炎症方面发挥了与罗伊氏乳杆菌BBC3类似的作用,可改善生长性能、降低死亡率并减少肠道损伤。LrEVs抑制了空肠中LPS诱导的促炎基因(TNF-α、IL-1β、IL-6、IL-17和IL-8)的表达,并提高了抗炎基因(IL-10和TGF-β)的表达。LrEVs可被鸡巨噬细胞内化。在体外,用LrEVs预处理通过抑制NF-κB活性降低了TNF-α、IL-1β和IL-6的基因表达,并增强了LPS激活的鸡巨噬细胞中IL-10和TGF-β的基因表达。此外,LrEVs可通过激活巨噬细胞抑制LPS刺激的鸡脾脏淋巴细胞中Th1和Th17介导的炎症反应,并增强免疫调节细胞介导的免疫抑制。最后,我们发现在离体实验中,囊泡蛋白和核酸含量的降低减弱了LrEVs对LPS诱导的炎症反应的抑制作用,表明它们对于LrEVs介导的免疫调节至关重要。
我们揭示了LrEVs参与维持鸡模型中肠道免疫稳态以抵抗LPS诱导的炎症反应。我们的研究结果为共生和益生菌罗伊氏乳杆菌在病原体诱导的炎症中如何调节宿主免疫系统提供了机制性见解。